|
1
|
Roewert-Huber J, Lange-Asschenfeldt B,
Stockfleth E and Kerl H: Epidemiology and aetiology of basal cell
carcinoma. Br J Dermatol. 157 (Suppl 2):S47–S51. 2007. View Article : Google Scholar
|
|
2
|
Correia de Sá TR, Silva R and Lopes JM:
Basal cell carcinoma of the skin (part 1): Epidemiology, pathology
and genetic syndromes. Future Oncol. 11:3011–3021. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong CS, Strange RC and Lear JT: Basal
cell carcinoma. BMJ. 327:794–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lomas A, Leonardi-Bee J and Bath-Hextall
F: A systematic review of worldwide incidence of nonmelanoma skin
cancer. Br J Dermatol. 166:1069–1080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rubin AI, Chen EH and Ratner D: Basal-cell
carcinoma. N Engl J Med. 353:2262–2269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martincorena I, Fowler JC, Wabik A, Lawson
ARJ, Abascal F, Hall MWJ, Cagan A, Murai K, Mahbubani K, Stratton
MR, et al: Somatic mutant clones colonize the human esophagus with
age. Science. 362:911–917. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martincorena I, Roshan A, Gerstung M,
Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB,
Tubio JM, et al: Tumor evolution. High burden and pervasive
positive selection of somatic mutations in normal human skin.
Science. 348:880–886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie J, Aszterbaum M, Zhang X, Bonifas JM,
Zachary C, Epstein E and McCormick F: A role of PDGFRalpha in basal
cell carcinoma proliferation. Proc Natl Acad Sci USA. 98:9255–9259.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Svärd J, Heby-Henricson K, Persson-Lek M,
Rozell B, Lauth M, Bergström A, Ericson J, Toftgård R and Teglund
S: Genetic elimination of Suppressor of fused reveals an essential
repressor function in the mammalian hedgehog signaling pathway. Dev
Cell. 10:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vogt A, Chuang PT, Hebert J, Hwang J, Lu
Y, Kopelovich L, Athar M, Bickers DR and Epstein EJ Jr:
Immunoprevention of basal cell carcinomas with recombinant
hedgehog-interacting protein. J Exp Med. 199:753–761. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Athar M, Tang X, Lee JL, Kopelovich L and
Kim AL: Hedgehog signalling in skin development and cancer. Exp
Dermatol. 15:667–677. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Epstein EH: Basal cell carcinomas: Attack
of the hedgehog. Nat Rev Cancer. 8:743–754. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Athar M, Li C, Tang X, Chi S, Zhang X, Kim
AL, Tyring SK, Kopelovich L, Hebert J, Epstein EJ Jr, et al:
Inhibition of smoothened signaling prevents ultraviolet B-induced
basal cell carcinomas through regulation of Fas expression and
apoptosis. Cancer Res. 64:7545–7552. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie J, Murone M, Luoh SM, Ryan A, Gu Q,
Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, et al: Activating
smoothened mutations in sporadic basal-cell carcinoma. Nature.
391:90–92. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lum L and Beachy PA: The hedgehog response
network: Sensors, switches, and routers. Science. 304:1755–1759.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim MY, Park HJ, Baek SC, Byun DG and Houh
D: Mutations of the p53 and PTCH gene in basal cell carcinomas: UV
mutation signature and strand bias. J Dermatol Sci. 29:1–9. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gailani MR, Ståhle-Bäckdahl M, Leffell DJ,
Glynn M, Zaphiropoulos PG, Pressman C, Undén AB, Dean M, Brash DE,
Bale AE and Toftgård R: The role of the human homologue of
Drosophila patched in sporadic basal cell carcinomas. Nat Genet.
14:78–81. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim J, Aftab BT, Tang JY, Kim D, Lee AH,
Rezaee M, Kim J, Chen B, King EM, Borodovsky A, et al: Itraconazole
and arsenic trioxide inhibit Hedgehog pathway activation and tumor
growth associated with acquired resistance to smoothened
antagonists. Cancer Cell. 23:23–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bii VM, Rae DT and Trobridge GD: A novel
gammaretroviral shuttle vector insertional mutagenesis screen
identifies SHARPIN as a breast cancer metastasis gene and
prognostic biomarker. Oncotarget. 6:39507–39520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stieglitz B, Haire LF, Dikic I and
Rittinger K: Structural analysis of SHARPIN, a subunit of a large
multi-protein E3 ubiquitin ligase, reveals a novel dimerization
function for the pleckstrin homology superfold. J Biol Chem.
287:20823–20829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ikeda F, Deribe YL, Skånland SS, Stieglitz
B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V,
Terzic J, et al: SHARPIN forms a linear ubiquitin ligase complex
regulating NF-κB activity and apoptosis. Nature. 471:637–641. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Wang Y, Gong Y, Fu T, Hu S, Zhou Z
and Pan L: Structural insights into SHARPIN-mediated Activation of
HOIP for the linear ubiquitin Chain assembly. Cell Rep. 21:27–36.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fujita H, Tokunaga A, Shimizu S, Whiting
AL, Aguilar-Alonso F, Takagi K, Walinda E, Sasaki Y, Shimokawa T,
Mizushima T, et al: Cooperative domain formation by homologous
motifs in HOIL-1L and SHARPIN plays a crucial role in LUBAC
stabilization. Cell Rep. 23:1192–1204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shimizu S, Fujita H, Sasaki Y, Tsuruyama
T, Fukuda K and Iwai K: Differential involvement of the Npl4 zinc
finger domains of SHARPIN and HOIL-1L in linear ubiquitin Chain
assembly complex-mediated cell death protection. Mol Cell Biol.
36:1569–1583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang Y, Seymour RE and Sundberg JP:
Inhibition of NF-κB signaling retards eosinophilic dermatitis in
SHARPIN-deficient mice. J Invest Dermatol. 131:141–149. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jung J, Kim JM, Park B, Cheon Y, Lee B,
Choo SH, Koh SS and Lee S: Newly identified tumor-associated role
of human Sharpin. Mol Cell Biochem. 340:161–167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang H, Yu S, Wang W, Li X, Hou Y, Liu Z,
Shi Y, Mu K, Niu G, Xu J, et al: SHARPIN facilitates p53
degradation in breast cancer cells. Neoplasia. 19:84–92. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Lai Y, Cao Y, Du T, Zeng L, Wang G,
Chen X, Chen J, Yu Y, Zhang S, et al: SHARPIN overexpression
induces tumorigenesis in human prostate cancer LNCaP, DU145 and
PC-3 cells via NF-κB/ERK/Akt signaling pathway. Med Oncol.
32:4442015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Queisser MA, Dada LA, Deiss-Yehiely N,
Angulo M, Zhou G, Kouri FM, Knab LM, Liu J, Stegh AH, DeCamp MM, et
al: HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung
tumor growth. Am J Respir Crit Care Med. 190:688–698. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen B, Zheng Y, Zhu J and Liang Y:
SHARPIN overexpression promotes TAK1 expression and activates JNKs
and NF-κB pathway in Mycosis Fungoides. Exp Dermatol. 28:1279–1288.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou S, Liang Y, Zhang X, Liao L, Yang Y,
Ouyang W and Xu H: SHARPIN promotes melanoma progression via Rap1
signaling pathway. J Invest Dermatol. Aug 8–2019.(Epub ahead of
print).
|
|
32
|
Kasperczyk H, Baumann B, Debatin KM and
Fulda S: Characterization of sonic hedgehog as a novel NF-kappaB
target gene that promotes NF-kappaB-mediated apoptosis resistance
and tumor growth in vivo. Faseb J. 23:21–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schumacher MA, Feng R, Aihara E, Engevik
AC, Montrose MH, Ottemann KM and Zavros Y: Helicobacter
pylori-induced Sonic Hedgehog expression is regulated by NFκB
pathway activation: The use of a novel in vitro model to study
epithelial response to infection. Helicobacter. 20:19–28. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yamasaki A, Kameda C, Xu R, Tanaka H,
Tasaka T, Chikazawa N, Suzuki H, Morisaki T, Kubo M, Onishi H, et
al: Nuclear factor kappaB-activated monocytes contribute to
pancreatic cancer progression through the production of Shh. Cancer
Immunol Immunother. 59:675–686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vile GF, Tanew-Ilitschew A and Tyrrell RM:
Activation of NF-kappa B in human skin fibroblasts by the oxidative
stress generated by UVA radiation. Photochem Photobiol. 62:463–468.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang SC, Liao PY, Hung SJ, Ge JS, Chen SM,
Lai JC, Hsiao YP and Yang JH: Topical application of glycolic acid
suppresses the UVB induced IL-6, IL-8, MCP-1 and COX-2 inflammation
by modulating NF-κB signaling pathway in keratinocytes and mice
skin. J Dermatol Sci. 86:238–248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Simon MM, Aragane Y, Schwarz A, Luger TA
and Schwarz T: UVB light induces nuclear factor kappa B (NF kappa
B) activity independently from chromosomal DNA damage in cell-free
cytosolic extracts. J Invest Dermatol. 102:422–427. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Budwit-Novotny DA, McCarty KS, Cox EB,
Soper JT, Mutch DG, Creasman WT, Flowers JL and McCarty KJ:
Immunohistochemical analyses of estrogen receptor in endometrial
adenocarcinoma using a monoclonal antibody. Cancer Res.
46:5419–5425. 1986.PubMed/NCBI
|
|
39
|
Bollag G, Hirth P, Tsai J, Zhang J,
Ibrahim PN, Cho H, Spevak W, Zhang C, Zhang Y, Habets G, et al:
Clinical efficacy of a RAF inhibitor needs broad target blockade in
BRAF-mutant melanoma. Nature. 467:596–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bai J, Kito Y, Okubo H, Nagayama T and
Takeuchi T: Expression of ZNF396 in basal cell carcinoma. Arch
Dermatol Res. 306:399–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Di Gennaro P, Sestini R, Bacci S, Pacini
A, Pinzani P, Domenici L, Toscano A, Massi D, Carli P, Genuardi M
and Romagnoli P: Tacrolimus causes reduced GLI1 expression and
phenotypic changes in the TE 354.T basal cell carcinoma cell line.
J Dermatol Sci. 54:52–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Colombo I, Sangiovanni E, Maggio R,
Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA,
Scaccabarozzi D, et al: HaCaT cells as a reliable in vitro
differentiation model to dissect the inflammatory/repair response
of human keratinocytes. Mediators Inflamm. 2017:74356212017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang XY, Wu B, Ma S, Yin L, Wu MC and Li
AJ: Decreased expression of ZWINT is associated with poor prognosis
in patients with HCC after surgery. Technol Cancer Res Treat.
17:15330338187941902018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Y, Huang H, Zhou H, Du T, Zeng L,
Cao Y, Chen J, Lai Y, Li J, Wang G and Guo Z: Activation of nuclear
factor κB pathway and downstream targets survivin and livin by
SHARPIN contributes to the progression and metastasis of prostate
cancer. Cancer. 120:3208–3218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
De Melo J and Tang D: Elevation of SIPL1
(SHARPIN) increases breast cancer risk. PLoS One. 10:e1275462015.
View Article : Google Scholar
|
|
47
|
Miller SJ: Biology of basal cell carcinoma
(Part I). J Am Acad Dermatol. 24:1–13. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Susnow N, Zeng L and Margineantu D: Bcl-2
family proteins as regulators of oxidative stress. Semin Cancer
Biol. 19:42–49. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ho A and Dowdy SF: Regulation of G(1)
cell-cycle progression by oncogenes and tumor suppressor genes.
Curr Opin Genet Dev. 12:47–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Purba TS, Brunken L, Hawkshaw NJ, Peake M,
Hardman J and Paus R: A primer for studying cell cycle dynamics of
the human hair follicle. Exp Dermatol. 25:663–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dante RA, Larkins BA and Sabelli PA: Cell
cycle control and seed development. Front Plant Sci. 5:4932014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fernández-Hernández R, Rafel M, Fusté NP,
Aguayo RS, Casanova JM, Egea J, Ferrezuelo F and Gari E: Cyclin D1
localizes in the cytoplasm of keratinocytes during skin
differentiation and regulates cell-matrix adhesion. Cell Cycle.
12:2510–2517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu W and McArthur G: Cell cycle regulation
and melanoma. Curr Oncol Rep. 18:342016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Duronio RJ and Xiong Y: Signaling pathways
that control cell proliferation. Cold Spring Harb Perspect Biol.
5:a0089042013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Otsuka A, Levesque MP, Dummer R and
Kabashima K: Hedgehog signaling in basal cell carcinoma. J Dermatol
Sci. 78:95–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Daya-Grosjean L and Couvé-Privat S: Sonic
hedgehog signaling in basal cell carcinomas. Cancer Lett.
225:181–192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mimeault M, Johansson SL, Vankatraman G,
Moore E, Henichart JP, Depreux P, Lin MF and Batra SK: Combined
targeting of epidermal growth factor receptor and hedgehog
signaling by gefitinib and cyclopamine cooperatively improves the
cytotoxic effects of docetaxel on metastatic prostate cancer cells.
Mol Cancer Ther. 6:967–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Neill GW, Harrison WJ, Ikram MS, Williams
TDL, Bianchi LS, Nadendla SK, Green JL, Ghali L, Frischauf AM,
O'Toole EA, et al: GLI1 repression of ERK activity correlates with
colony formation and impaired migration in human epidermal
keratinocytes. Carcinogenesis. 29:738–746. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Riobó NA, Lu K, Ai X, Haines GM and
Emerson CP Jr: Phosphoinositide 3-kinase and Akt are essential for
sonic hedgehog signaling. Proc Natl Acad Sci USA. 103:4505–4510.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Schnidar H, Eberl M, Klingler S,
Mangelberger D, Kasper M, Hauser-Kronberger C, Regl G, Kroismayr R,
Moriggl R, Sibilia M and Aberger F: Epidermal growth factor
receptor signaling synergizes with Hedgehog/GLI in oncogenic
transformation via activation of the MEK/ERK/JUN pathway. Cancer
Res. 69:1284–1292. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Laner-Plamberger S, Kaser A, Paulischta M,
Hauser- Kronberger C, Eichberger T and Frischauf AM: Cooperation
between GLI and JUN enhances transcription of JUN and selected GLI
target genes. Oncogene. 28:1639–1651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Albanese C, Johnson J, Watanabe G, Eklund
N, Vu D, Arnold A and Pestell RG: Transforming p21ras mutants and
c-Ets-2 activate the cyclin D1 promoter through distinguishable
regions. J Biol Chem. 270:23589–23597. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Johnson GL and Nakamura K: The c-jun
kinase/stress-activated pathway: Regulation, function and role in
human disease. Biochim Biophys Acta. 1773:1341–1348. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Morrison DK: MAP kinase pathways. Cold
Spring Harb Perspect Biol. 4:2012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhao HF, Wang J, Jiang HR, Chen ZP and To
SS: PI3K p110β isoform synergizes with JNK in the regulation of
glioblastoma cell proliferation and migration through Akt and FAK
inhibition. J Exp Clin Cancer Res. 35:782016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Johnson RS, Van Lingen B, Papaioannou VE
and Spiegelman BM: A null mutation at the c-jun locus causes
embryonic lethality and retarded cell growth in culture. Genes Dev.
7:1309–1317. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zenz R, Scheuch H, Martin P, Frank C,
Eferl R, Kenner L, Sibilia M and Wagner EF: c-Jun regulates eyelid
closure and skin tumor development through EGFR signaling. Dev
Cell. 4:879–889. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zenz R and Wagner EF: Jun signalling in
the epidermis: From developmental defects to psoriasis and skin
tumors. Int J Biochem Cell Biol. 38:1043–1049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Regl G, Kasper M, Schnidar H, Eichberger
T, Neill GW, Ikram MS, Quinn AG, Philpott MP, Frischauf AM and
Aberger F: The zinc-finger transcription factor GLI2 antagonizes
contact inhibition and differentiation of human epidermal cells.
Oncogene. 23:1263–1274. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gerlach B, Cordier SM, Schmukle AC,
Emmerich CH, Rieser E, Haas TL, Webb AI, Rickard JA, Anderton H,
Wong WW, et al: Linear ubiquitination prevents inflammation and
regulates immune signalling. Nature. 471:591–596. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tokunaga F, Nakagawa T, Nakahara M, Saeki
Y, Taniguchi M, Sakata S, Tanaka K, Nakano H and Iwai K: SHARPIN is
a component of the NF-κB-activating linear ubiquitin chain assembly
complex. Nature. 471:633–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sivrikoz NO and Kandiloğlu G: The effects
of cyclin D1 and Bcl-2 expression on aggressive behavior in basal
cell and basosquamous carcinoma. Iran J Pathol. 10:185–191.
2015.PubMed/NCBI
|
|
75
|
Liang SB, Furihata M, Takeuchi T, Iwata J,
Chen BK, Sonobe H and Ohtsuki Y: Overexpression of cyclin D1 in
nonmelanocytic skin cancer. Virchows Arch. 436:370–376. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Huang K, Huang C, Shan K, Chen J and Li H:
Significance of PC cell-derived growth factor and cyclin D1
expression in cutaneous squamous cell carcinoma. Clin Exp Dermatol.
37:411–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bladen JC, Moosajee M, Tracey-White D,
Beaconsfield M, O Toole EA and Philpott MP: Analysis of hedgehog
signaling in periocular sebaceous carcinoma. Graefes Arch Clin Exp
Ophthalmol. 256:853–860. 2018. View Article : Google Scholar : PubMed/NCBI
|
